| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:04:34 UTC |
|---|
| Update date | 2019-11-26 02:54:50 UTC |
|---|
| Primary ID | FDB000453 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Theophylline |
|---|
| Description | Theophylline, also known as uniphyl or aerolate, belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. Theophylline is an extremely weak basic (essentially neutral) compound (based on its pKa). Theophylline is a bitter tasting compound. Theophylline is found, on average, in the highest concentration within cocoa beans and tea. Theophylline has also been detected, but not quantified in, several different foods, such as arabica coffee, guarana, lemons, pummelo, and robusta coffee. This could make theophylline a potential biomarker for the consumption of these foods. Theophylline is a potentially toxic compound. |
|---|
| CAS Number | 58-55-9 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 1,3-Dimethyl-7H-purine-2,6-dione | ChEBI | | 1,3-Dimethylxanthine | ChEBI | | Elixophyllin | ChEBI | | Respbid | ChEBI | | Theo-dur | ChEBI | | Theolair | ChEBI | | Theophyllin | ChEBI | | Theophylline anhydrous | ChEBI | | Uniphyl | ChEBI | | Quibron-t | Kegg | | Theo-24 | Kegg | | Theodur g | Kegg | | Accurbron | HMDB | | Acet-theocin | HMDB | | Aerolate | HMDB | | Aerolate III | HMDB | | Aerolate SR | HMDB | | Aminophylline | HMDB | | Aquaphyllin | HMDB | | Armophylline | HMDB | | Asbron | HMDB | | Asmax | HMDB | | Austyn | HMDB | | Bronkodyl | HMDB | | Bronkodyl SR | HMDB | | Choledyl sa | HMDB | | Constant-T | HMDB | | Diphyllin | HMDB | | Doraphyllin | HMDB | | Duraphyl | HMDB | | Dyspne-inhal | HMDB | | Elixex | HMDB | | Elixicon | HMDB | | Elixomin | HMDB | | Elixophyllin SR | HMDB | | Elixophylline | HMDB | | Euphylline | HMDB | | Euphylong | HMDB | | Labid | HMDB | | Lanophyllin | HMDB | | Liquophylline | HMDB | | Liquorice | HMDB | | Maphylline | HMDB | | Medaphyllin | HMDB | | Nuelin | HMDB | | Optiphyllin | HMDB | | Parkophyllin | HMDB | | Pseudotheophylline | HMDB | | Quibron t/sr | HMDB | | Quibron-t/sr | HMDB | | Slo-bid | HMDB | | Slo-phyllin | HMDB | | Solosin | HMDB | | Somophyllin-CRT | HMDB | | Somophyllin-DF | HMDB | | Somophyllin-T | HMDB | | Spophyllin retard | HMDB | | Sustaire | HMDB | | Synophylate | HMDB | | Synophylate-l.a. cenules | HMDB | | T-Phyl | HMDB | | Tefamin | HMDB | | Teofilina | HMDB | | Teofyllamin | HMDB | | Teolair | HMDB | | Theacitin | HMDB | | Theal tabl. | HMDB | | Theal tablets | HMDB | | Theo-dur-sprinkle | HMDB | | Theobid | HMDB | | Theobid jr. | HMDB | | Theochron | HMDB | | Theocin | HMDB | | Theoclair-SR | HMDB | | Theoclear 80 | HMDB | | Theoclear l.a.-130 | HMDB | | Theoclear la | HMDB | | Theoclear-200 | HMDB | | Theoclear-80 | HMDB | | Theocontin | HMDB | | Theodel | HMDB | | Theofol | HMDB | | Theograd | HMDB | | Theolair-SR | HMDB | | Theolix | HMDB | | Theolixir | HMDB | | Theona p | HMDB | | Theophyl | HMDB | | Theophyl-225 | HMDB | | Theophyl-SR | HMDB | | Theophyline | HMDB | | Theophylline-SR | HMDB | | Theostat 80 | HMDB | | Theovent | HMDB | | Uni-dur | HMDB | | Unifyl | HMDB | | Uniphyllin | HMDB | | Xanthium | HMDB | | Xantivent | HMDB | | Aerobin | HMDB | | Bronchoparat | HMDB | | Glycine theophyllinate | HMDB | | Nuelin s.a. | HMDB | | Slo phyllin | HMDB | | SloPhyllin | HMDB | | Somophyllin T | HMDB | | Theo24 | HMDB | | Theoconfin continuous | HMDB | | Theonite | HMDB | | CT Arzneimittel brand OF theophylline sodium glycinate | HMDB | | Von CT, theo | HMDB | | Mundipharma brand OF theophylline sodium glycinate | HMDB | | Quibron T SR | HMDB | | Quibron T-SR | HMDB | | Sodium glycinate, theophylline | HMDB | | Theo 24 | HMDB | | Theophyllinate, glycine | HMDB | | Theophylline sodium glycinate | HMDB | | Theospan | HMDB | | Uniphylline | HMDB | | CT-Arzneimittel brand OF theophylline sodium glycinate | HMDB | | ConstantT | HMDB | | Fameasan brand OF theophylline sodium glycinate | HMDB | | Lodrane | HMDB | | Monospan | HMDB | | Quibron TSR | HMDB | | Theodur | HMDB | | Theon | HMDB | | Theopek | HMDB | | Theostat | HMDB | | CT, Theo von | HMDB | | Theo von CT | HMDB | | 1,3 Dimethylxanthine | HMDB | | 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione | HMDB | | Afonilum retard | HMDB | | Anhydrous, theophylline | HMDB | | Constant T | HMDB | | Fujisawa brand OF theophylline sodium glycinate | HMDB | | Glycinate, theophylline sodium | HMDB | | SomophyllinT | HMDB | | Theo dur | HMDB | | 1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine | biospider | | 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione | biospider | | 1,3-Dimethyl-3,9-dihydro-1H-purine-2,6-dione | biospider | | 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl- | biospider | | 1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl- | biospider | | 2,6-Dihydroxy-1,3-dimethylpurine | biospider | | 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione, 9CI | db_source | | Aerolate sr | HMDB | | Bronkodyl sr | HMDB | | Constant-t | HMDB | | Elixophyllin sr | HMDB | | Labophylline | biospider | | Mudrane | biospider | | Purine-2,6(1H,3H)-dione, 1,3-dimethyl- | biospider | | Slophyllin | biospider | | Somophyllin-crt | HMDB | | Somophyllin-df | HMDB | | Somophyllin-t | HMDB | | T-phyl | HMDB | | Teonova | db_source | | Theoclair-sr | HMDB | | Theokin | biospider | | Theolair-sr | HMDB | | Theona P | HMDB | | Theophyl-sr | HMDB | | Theophylline-sr | HMDB | | Xanthine, 1,3-dimethyl- | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C7H8N4O2 |
|---|
| IUPAC name | 1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione |
|---|
| InChI Identifier | InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9) |
|---|
| InChI Key | ZFXYFBGIUFBOJW-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | CN1C2=C(NC=N2)C(=O)N(C)C1=O |
|---|
| Average Molecular Weight | 180.164 |
|---|
| Monoisotopic Molecular Weight | 180.06472552 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Imidazopyrimidines |
|---|
| Sub Class | Purines and purine derivatives |
|---|
| Direct Parent | Xanthines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Xanthine
- 6-oxopurine
- Purinone
- Alkaloid or derivatives
- Pyrimidone
- Pyrimidine
- Azole
- Imidazole
- Heteroaromatic compound
- Vinylogous amide
- Lactam
- Urea
- Azacycle
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Process | Naturally occurring process: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Foods | Cocoa and cocoa products Beverages: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 46.67%; H 4.48%; N 31.10%; O 17.76% | DFC |
|---|
| Melting Point | Mp 264° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 7.36 mg/mL at 25 oC | YALKOWSKY,SH & HE,Y (2003) |
|---|
| Experimental logP | -0.02 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | pKa2 8.6 (25°) | DFC |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-00lr-9500000000-2c8464c2fe84464c207f | 2014-09-20 | View Spectrum | | GC-MS | Theophylline, 1 TMS, GC-MS Spectrum | splash10-0f79-6970000000-224461ad62a44dbdf860 | Spectrum | | GC-MS | Theophylline, non-derivatized, GC-MS Spectrum | splash10-001j-7900000000-a08735d528e738752429 | Spectrum | | GC-MS | Theophylline, non-derivatized, GC-MS Spectrum | splash10-001i-0900000000-d0882f7d959c726e7623 | Spectrum | | GC-MS | Theophylline, non-derivatized, GC-MS Spectrum | splash10-001i-9700000000-8d0e1898a6571fbca10a | Spectrum | | GC-MS | Theophylline, non-derivatized, GC-MS Spectrum | splash10-0f79-6970000000-224461ad62a44dbdf860 | Spectrum | | Predicted GC-MS | Theophylline, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0fka-4900000000-878cab6882fd80efba3b | Spectrum | | Predicted GC-MS | Theophylline, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-00di-0900000000-0092516012d6a2a93b31 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-00di-4900000000-dcf52c18a6996f412b1a | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-00kf-9000000000-09089337909892ef44cb | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - EI-B (Unknown) , Positive | splash10-001j-7900000000-a08735d528e738752429 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - CI-B (Unknown) , Positive | splash10-001i-0900000000-d0882f7d959c726e7623 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-004i-0900000000-c4943571126a44bb9e5a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-004i-0900000000-bc12ce29acd02fa749b8 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-03k9-0900000000-d63f60043f186fbb9bc0 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-070l-4900000000-d293ab2fa6199dbaf97a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-05ru-9400000000-dde4775588d52c83806f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-004i-0900000000-556e382f583d610ef1f0 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-004i-0900000000-89e34f5158856ba33469 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-03k9-0900000000-65a6897d72954e875b00 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-070l-4900000000-df16604bd6c40cee8f24 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-05r3-9500000000-39a721dcecc86ed95507 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-001i-1900000000-e67ff7ef9a955b90eb3f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-001i-3900000000-1870952d98dbba22ace8 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-00di-7900000000-dc0e9606776c43a7823f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-014j-9300000000-2c4c6490dda3ed3b563f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014i-9000000000-26a6c0c23a465afdcde1 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-01q9-1900000000-b11ca3441bb29fef1906 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-0002-9400000000-63726fe0b49a9dc6ba7e | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-00di-9100000000-139f765bc9b5855960c6 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-00di-9000000000-88b5cb393b960973ac64 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-00yi-9000000000-1ebbddce3c7133972546 | 2012-08-31 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 90 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 15.09 MHz, DMSO-d6, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 2068 |
|---|
| ChEMBL ID | CHEMBL190 |
|---|
| KEGG Compound ID | C07130 |
|---|
| Pubchem Compound ID | 2153 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 28177 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00277 |
|---|
| HMDB ID | HMDB01889 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | BCK73-S:BCK73-S |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | THEOPHYLLINE| DIMETHYLXANTHINE |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | C00001510 |
|---|
| HET ID | TEP |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Theophylline |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| (+)-inotropic | | An agent that increases the force or energy of muscular contractions, particularly in the heart. It plays a biological role in enhancing cardiac output and is therapeutically used to treat heart failure, cardiogenic shock, and other cardiovascular conditions, improving cardiac function and overall circulation. | DUKE | | Allergenic | 50904 | A substance that triggers an immune response, causing allergic reactions. Its biological role is to stimulate the immune system, but it has no therapeutic applications. Key medical uses include diagnosing allergies and developing immunotherapies to desensitize patients to specific allergens, reducing the risk of severe reactions. | DUKE | | Anti-apneic | 52217 | An agent that stimulates breathing, used to treat respiratory disorders such as apnea, promoting normal respiratory function and preventing oxygen deprivation. | DUKE | | Anti-asthmatic | 49167 | An agent that relieves bronchospasm and inflammation, commonly used to manage asthma symptoms, chronic obstructive pulmonary disease (COPD), and other respiratory disorders, improving lung function and overall respiratory health. | DUKE | | Anti bradyarrhythmic | 38070 | An agent that increases heart rate, counteracting abnormally slow heart rhythms. It is used to treat bradyarrhythmias, such as atrioventricular block, and is commonly used in emergency medicine and cardiology to restore normal heart function. | DUKE | | Anti-bronchitic | 52217 | An agent that relieves bronchial congestion and inflammation, commonly used in managing respiratory disorders such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD), to reduce coughing, wheezing, and shortness of breath. | DUKE | | Anti cellulitic | 52217 | An agent that reduces the appearance of cellulite, improving skin texture and tone. It enhances blood flow, breaks down fat cells, and strengthens connective tissue, commonly used in cosmetic and dermatological treatments to minimize dimpling and orange peel skin. | DUKE | | Antidote | 50247 | An agent that counteracts a poison or toxin, neutralizing its harmful effects. It plays a biological role in reversing toxicity, and has therapeutic applications in treating poisoning, overdose, and envenomation. Key medical uses include emergency treatment for snake bites, drug overdose, and chemical exposure. | DUKE | | Anti emphysemic | 52217 | An agent that protects against emphysema, a lung disease. It helps maintain lung function, reduces inflammation, and prevents damage to alveoli. Therapeutically, anti-emphysemics are used to manage chronic obstructive pulmonary disease (COPD) and other respiratory disorders, improving breathing and overall lung health. | DUKE | | Anti neuralgic | 52217 | An agent that relieves nerve pain, reducing inflammation and discomfort. It plays a biological role in blocking pain pathways, and has therapeutic applications in managing conditions like trigeminal neuralgia, shingles, and diabetic neuropathy. Key medical uses include treating severe nerve pain, numbness, and tingling sensations. | DUKE | | Anti-rhinitic | 52217 | An agent that relieves nasal congestion and allergic rhinitis symptoms, reducing inflammation and histamine release. Therapeutically, it's used to manage rhinitis, sinusitis, and allergic reactions, providing relief from sneezing, runny nose, and itchy eyes. | DUKE | | Anti-spasmodic | 52217 | An agent that relaxes smooth muscle, reducing muscle spasms and cramps. It plays a biological role in regulating muscle tone and is therapeutically applied to treat conditions such as irritable bowel syndrome, menstrual cramps, and muscle spasms, providing relief from abdominal pain and discomfort. | DUKE | | Anti-viral | 22587 | An agent that inhibits the replication of viruses, playing a crucial role in preventing and treating viral infections. Therapeutically, anti-virals are used to manage diseases such as HIV, herpes, and influenza, reducing symptoms and slowing disease progression. Key medical uses include treating viral hepatitis, respiratory syncytial virus, and COVID-19. | DUKE | | Arteriodilator | | An agent that dilates arteries, increasing blood flow to or from the heart, used therapeutically to manage conditions like hypertension, heart failure, and angina, improving cardiac output and reducing blood pressure. | DUKE | | Bronchodilator | 35523 | An agent that relaxes airway muscles, increasing airflow to the lungs. It reduces bronchospasm, commonly used in managing asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders to improve breathing and relieve symptoms. | DUKE | | cAMP inhibitor | 35222 | An agent that blocks the activity of cyclic adenosine monophosphate (cAMP), a key signaling molecule. It reduces intracellular cAMP levels, modulating various biological processes. Therapeutically, cAMP inhibitors are used to treat conditions like asthma, cancer, and cardiovascular diseases by regulating cell signaling pathways and inflammation. | DUKE | | cAMP-phosphodiesterase inhibitor | 23924 | An agent that blocks the breakdown of cyclic adenosine monophosphate (cAMP), increasing its levels and enhancing cellular signaling. Therapeutically, it is used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), as well as certain cardiovascular conditions. | DUKE | | Cardiovascular | 38070 | A system that transports blood, oxygen, and nutrients throughout the body, playing a crucial role in overall health. Therapeutically, cardiovascular agents manage conditions like hypertension, heart failure, and atherosclerosis, with key medical uses including regulating blood pressure, preventing blood clots, and improving cardiac function. | DUKE | | cGMP inhibitor | 35222 | An agent that blocks the activity of cyclic guanosine monophosphate (cGMP), reducing its signaling effects. It has therapeutic applications in treating conditions like priapism and pulmonary hypertension, and key medical uses include managing erectile dysfunction side effects and certain cardiovascular disorders. | DUKE | | cGMP-phosphodiesterase inhibitor | 23924 | An agent that blocks the breakdown of cyclic guanosine monophosphate (cGMP), increasing its levels. It relaxes smooth muscle, dilates blood vessels, and improves cardiac function. Therapeutically used to treat erectile dysfunction, pulmonary hypertension, and heart failure, improving exercise tolerance and quality of life. | DUKE | | Choleretic | | An agent that increases bile production and secretion from the liver, enhancing digestion and fat absorption. Therapeutically, it's used to treat gallstones, liver disease, and indigestion, promoting healthy bile flow and liver function. | DUKE | | Central nervous system stimulant | 35470 | An agent that increases alertness and activity by enhancing neurotransmitter release, used therapeutically to manage attention deficit hyperactivity disorder (ADHD), narcolepsy, and fatigue, and to improve cognitive function and mood. | DUKE | | Diuretic | 35498 | An agent that increases urine production, helping remove excess fluids and salts from the body. It plays a key biological role in regulating fluid balance and blood pressure. Therapeutically, diuretics are used to treat conditions such as hypertension, edema, and heart failure, helping reduce swelling and lower blood pressure. | DUKE | | Fetotoxic | 52209 | An agent that is toxic to the fetus, causing harm or developmental issues during pregnancy. Its biological role is to induce fetal damage, and it has no therapeutic applications. Key medical uses include serving as a warning or contraindication for certain medications or substances during pregnancy to prevent fetal harm. | DUKE | | Herbicide | 24527 | A chemical agent that kills or inhibits plant growth, used in agriculture to control weeds and pests. It has no direct biological role or therapeutic applications in human medicine, but its development has led to the creation of related compounds with potential medical uses, such as anticancer agents. | DUKE | | Hypertensive | | An agent that increases blood pressure, used therapeutically to treat hypotension (low blood pressure) and shock, and medically to manage conditions such as orthostatic hypotension and postural hypotension. | DUKE | | Hyperuricemic | | An agent that increases uric acid levels in the blood, playing a role in gout development. Therapeutically, it has limited applications, but is used in research to study gout and uric acid metabolism. Medically, it is used to induce gout-like conditions in clinical trials, aiding in the development of treatments for gout and other uric acid-related disorders. | DUKE | | Hypoglycemic | 35526 | An agent that lowers blood glucose levels, playing a crucial role in glucose metabolism. Therapeutically, it is used to manage diabetes and insulin resistance, with key medical applications in treating type 1 and 2 diabetes, and preventing diabetic complications. | DUKE | | Myocardiotonic | 38070 | An agent that strengthens heart muscle contractions, enhancing cardiac function. It plays a biological role in increasing cardiac output and reducing symptoms of heart failure. Therapeutically, myocardiotonics are used to manage conditions like cardiomyopathy, heart failure, and coronary artery disease, improving overall cardiac performance. | DUKE | | Myorelaxant | | An agent that reduces muscle contractility by blocking nerve impulses or decreasing motor end plate excitability, used therapeutically to relieve muscle spasms, tension, and pain, commonly in managing musculoskeletal disorders, anxiety, and insomnia. | DUKE | | Pesticide | 25944 | An agent that kills or repels pests, playing a biological role in controlling insect, weed, and fungal populations. Therapeutically, pesticides have limited applications, but some are used to treat ectoparasitic infestations, such as lice and scabies. Key medical uses include topical treatments for head lice and scabies, highlighting their role in managing parasitic infections. | DUKE | | Prostaglandin secretor | | An agent that stimulates the release of prostaglandins, reducing gastric acid secretion and protecting the gastrointestinal mucosa. Therapeutically, it is used to prevent NSAID-induced ulcers and gastroesophageal reflux disease (GERD), and to manage conditions like Zollinger-Ellison syndrome. | DUKE | | Stimulant | | An agent that enhances alertness, wakefulness, and physical activity by increasing brain activity. Therapeutically, it is used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain cases of depression, improving focus, attention, and overall mental performance. | DUKE | | Tachycardic | 38070 | An agent that increases heart rate, playing a biological role in stress response and exercise. Therapeutically, it is used to manage bradycardia (abnormally slow heart rate) and cardiac arrest. Key medical uses include treating symptomatic bradycardia, Adams-Stokes syndrome, and asystole, helping to restore normal heart rhythm and maintain adequate blood circulation. | DUKE | | Teratogenic | 50905 | An agent that causes abnormal fetal development, disrupting embryonic growth and leading to birth defects. Its biological role is associated with developmental toxicity, and it has no therapeutic applications. Key medical uses include serving as a warning for substances that pose risks during pregnancy, guiding prenatal care and medication management to prevent birth defects. | DUKE | | Vasodilator | 35620 | An agent that widens blood vessels, reducing blood pressure and increasing blood flow. It plays a biological role in regulating cardiovascular function. Therapeutically, vasodilators are used to treat conditions such as hypertension, angina, and heart failure, improving oxygen delivery and reducing cardiac workload. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Adenosine deaminase | ADA | P00813 | | Adenosine receptor A1 | ADORA1 | P30542 | | Adenosine receptor A2a | ADORA2A | P29274 | | Adenosine receptor A2b | ADORA2B | P29275 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | | Flavor | Citations |
|---|
| bitter |
- Ayana Wiener, Marina Shudler, Anat Levit, Masha Y. Niv. BitterDB: a database of bitter compounds. Nucleic Acids Res 2012, 40(Database issue):D413-419. DOI:10.1093/nar/gkr755
|
|
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|